What is CortiCare?
CortiCare operates as a tele-EEG diagnostic company, founded with the premise of enabling clinicians to accurately and efficiently determine real-brain functionality and abnormalities. The company has been instrumental in redefining neuro-critical care and has expanded the application of in-home ambulatory EEG services. Furthermore, CortiCare provides crucial support for clinical trials, leveraging its technological capabilities to advance neurological research and patient care.
How much funding has CortiCare raised?
CortiCare has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in CortiCare
PPP
Public-Private Partnership
What's next for CortiCare?
The recent major strategic investment signals CortiCare's transition into a scaling phase, likely focusing on expanding its service reach and enhancing its technological infrastructure. This enterprise-level funding is expected to fuel further innovation in tele-neurology, potentially leading to broader adoption of its diagnostic solutions across healthcare systems and research institutions. The company is well-positioned to capitalize on the growing demand for remote patient monitoring and advanced diagnostic tools in the neuro-critical care sector.
See full CortiCare company page
